As a new organic conjugated semiconductor,graphitic carbon nitride(g-C_(3)N_(4))is emerging as a fascinating material for various photocatalytic applications due to its adjustable electronic structure,outstanding ther...As a new organic conjugated semiconductor,graphitic carbon nitride(g-C_(3)N_(4))is emerging as a fascinating material for various photocatalytic applications due to its adjustable electronic structure,outstanding thermal endurance,appealing chemical stability,low cost,and environmental friendliness.Nevertheless,unmodified bulk g-C_(3)N_(4) possesses some intrinsic limitations related to poor crystallinity,marginal visible-light harvesting,easy recombination of charge pairs,small surface area,and slow charge migration,which give rise to the low quantum efficiency of photocatalytic reactions.One efficient strategy to overcome these shortcomings is the manipulation of the microstructures of g-C_(3)N_(4).Other than the traditional structure control,mimicking the structures of creatures in nature to design and construct bio-inspired structures is a promising approach to improve the photocatalytic performance of g-C_(3)N_(4) and even g-C_(3)N_(4)-based systems.This review summarizes the recent advances of the traditional structure-control of g-C_(3)N_(4)-based systems,and bio-inspired synthesis of g-C_(3)N_(4)-based systems from two aspects of structural bionics and functional bionics.Furthermore,the fundamentals of bio-inspired design and fabrication of g-C_(3)N_(4)-based systems are introduced in detail.Additionally,the different theoretical calculations,diverse photocatalytic applications and various modification strategies of bio-inspired structured g-C_(3)N_(4)-based systems are recapped.We believe that this work will be a guiding star for future research in the new field of biomimetic photocatalysis.展开更多
AIM： To study the effect of a one-year lamivudine regimen in patients with chronic hepatitis B. METHODS： Medical records of HBeAg negative hepatitis B patients who attended a hepatitis clinic in Tehran between March...AIM： To study the effect of a one-year lamivudine regimen in patients with chronic hepatitis B. METHODS： Medical records of HBeAg negative hepatitis B patients who attended a hepatitis clinic in Tehran between March 2002-March 2004 were evaluated. The patients received 100 mg lamivudine tablets once daily for at least 12 mo. Liver enzymes and complete blood count were checked at baseline and the end of treatment （12th mo） and 6 mo after discontinuation of treatment. RESULTS： Of all patients, 24 were excluded. Of 71 patients left, 58 （81.7%） were men. Mean age of the patients was 38 ± 14 years. Mean level of ALT in serum was 1437 ± 205 nkat/L at baseline with a significant reduction at the end of treatment to a mean level of 723 ± 92 nkat/L （P = 0.002）. In 38 patients （53.5%）, the ALT level was normal after one-year treatment. Five patients （7.3%） relapsed （biochemically） within 6 mo after discontinuing lamivudine therapy （the patients with good end of treatment response）. Mean level of AST in serum was 1060 ± 105 nkat/L at baseline which decreased significantly to 652 ± 75 nkat/L at the end of treatment （P = 0.002）. CONCLUSION： Over half （53.5%） of chronic hepatitis B patients with HBeAg negative have normal liver enzyme level at 12-mo lamivudine therapy.展开更多
文摘As a new organic conjugated semiconductor,graphitic carbon nitride(g-C_(3)N_(4))is emerging as a fascinating material for various photocatalytic applications due to its adjustable electronic structure,outstanding thermal endurance,appealing chemical stability,low cost,and environmental friendliness.Nevertheless,unmodified bulk g-C_(3)N_(4) possesses some intrinsic limitations related to poor crystallinity,marginal visible-light harvesting,easy recombination of charge pairs,small surface area,and slow charge migration,which give rise to the low quantum efficiency of photocatalytic reactions.One efficient strategy to overcome these shortcomings is the manipulation of the microstructures of g-C_(3)N_(4).Other than the traditional structure control,mimicking the structures of creatures in nature to design and construct bio-inspired structures is a promising approach to improve the photocatalytic performance of g-C_(3)N_(4) and even g-C_(3)N_(4)-based systems.This review summarizes the recent advances of the traditional structure-control of g-C_(3)N_(4)-based systems,and bio-inspired synthesis of g-C_(3)N_(4)-based systems from two aspects of structural bionics and functional bionics.Furthermore,the fundamentals of bio-inspired design and fabrication of g-C_(3)N_(4)-based systems are introduced in detail.Additionally,the different theoretical calculations,diverse photocatalytic applications and various modification strategies of bio-inspired structured g-C_(3)N_(4)-based systems are recapped.We believe that this work will be a guiding star for future research in the new field of biomimetic photocatalysis.
文摘AIM： To study the effect of a one-year lamivudine regimen in patients with chronic hepatitis B. METHODS： Medical records of HBeAg negative hepatitis B patients who attended a hepatitis clinic in Tehran between March 2002-March 2004 were evaluated. The patients received 100 mg lamivudine tablets once daily for at least 12 mo. Liver enzymes and complete blood count were checked at baseline and the end of treatment （12th mo） and 6 mo after discontinuation of treatment. RESULTS： Of all patients, 24 were excluded. Of 71 patients left, 58 （81.7%） were men. Mean age of the patients was 38 ± 14 years. Mean level of ALT in serum was 1437 ± 205 nkat/L at baseline with a significant reduction at the end of treatment to a mean level of 723 ± 92 nkat/L （P = 0.002）. In 38 patients （53.5%）, the ALT level was normal after one-year treatment. Five patients （7.3%） relapsed （biochemically） within 6 mo after discontinuing lamivudine therapy （the patients with good end of treatment response）. Mean level of AST in serum was 1060 ± 105 nkat/L at baseline which decreased significantly to 652 ± 75 nkat/L at the end of treatment （P = 0.002）. CONCLUSION： Over half （53.5%） of chronic hepatitis B patients with HBeAg negative have normal liver enzyme level at 12-mo lamivudine therapy.
